These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21856956)

  • 41. [Non-pharmacological prevention of ventilator-associated pneumonia].
    Díaz LA; Llauradó M; Rello J; Restrepo MI
    Arch Bronconeumol; 2010 Apr; 46(4):188-95. PubMed ID: 19819060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit.
    Sona CS; Zack JE; Schallom ME; McSweeney M; McMullen K; Thomas J; Coopersmith CM; Boyle WA; Buchman TG; Mazuski JE; Schuerer DJ
    J Intensive Care Med; 2009; 24(1):54-62. PubMed ID: 19017665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreasing ventilator-associated pneumonia in a trauma ICU.
    Cocanour CS; Peninger M; Domonoske BD; Li T; Wright B; Valdivia A; Luther KM
    J Trauma; 2006 Jul; 61(1):122-9; discussion 129-30. PubMed ID: 16832259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study.
    Pronovost PJ; Goeschel CA; Colantuoni E; Watson S; Lubomski LH; Berenholtz SM; Thompson DA; Sinopoli DJ; Cosgrove S; Sexton JB; Marsteller JA; Hyzy RC; Welsh R; Posa P; Schumacher K; Needham D
    BMJ; 2010 Feb; 340():c309. PubMed ID: 20133365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthy work environments, nurse-physician communication, and patients' outcomes.
    Manojlovich M; DeCicco B
    Am J Crit Care; 2007 Nov; 16(6):536-43. PubMed ID: 17962497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventilator-associated pneumonia improvement program.
    Murray T; Goodyear-Bruch C
    AACN Adv Crit Care; 2007; 18(2):190-9. PubMed ID: 17473548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?
    Shorr AF; Micek ST; Jackson WL; Kollef MH
    Crit Care Med; 2007 May; 35(5):1257-62. PubMed ID: 17414080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Federal and nationwide intensive care units and healthcare costs: 1986-1992.
    Halpern NA; Bettes L; Greenstein R
    Crit Care Med; 1994 Dec; 22(12):2001-7. PubMed ID: 7988140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
    McGarry LJ; Merchant S; Nathwani D; Pawar V; DeLong K; Thompson D; Akhras K; Ingham M; Weinstein MC
    J Med Econ; 2010 Mar; 13(1):142-7. PubMed ID: 20136579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infection prevention and control in the intensive care unit: open versus closed models of care.
    Daneman N; Scales DC; Lawless B; Muscedere J; Blount V; Fowler RA
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):867-71. PubMed ID: 23838236
    [No Abstract]   [Full Text] [Related]  

  • 52. A Single-Center Multidisciplinary Initiative to Reduce Catheter-Associated Urinary Tract Infection Rates: Quality and Financial Implications.
    Sutherland T; Beloff J; McGrath C; Liu X; Pimentel MT; Kachalia A; Bates D; Urman RD
    Health Care Manag (Frederick); 2015; 34(3):218-24. PubMed ID: 26217997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ventilator-associated Pneumonia Prevention. Is It Worth It?
    Kollef MH
    Am J Respir Crit Care Med; 2015 Jul; 192(1):5-7. PubMed ID: 26131987
    [No Abstract]   [Full Text] [Related]  

  • 54. Reducing Three Infections Across Cardiac Surgery Programs: A Multisite Cross-Unit Collaboration.
    Chang BH; Hsu YJ; Rosen MA; Gurses AP; Huang S; Xie A; Speck K; Marsteller JA; Thompson DA
    Am J Med Qual; 2020; 35(1):37-45. PubMed ID: 31046400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing Harm in the ICU-Building a Culture of Safety and Engaging Patients and Families.
    Thornton KC; Schwarz JJ; Gross AK; Anderson WG; Liu KD; Romig MC; Schell-Chaple H; Pronovost PJ; Sapirstein A; Gropper MA; Lipshutz AKM;
    Crit Care Med; 2017 Sep; 45(9):1531-1537. PubMed ID: 28640023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using a logic model to design and evaluate quality and patient safety improvement programs.
    Goeschel CA; Weiss WM; Pronovost PJ
    Int J Qual Health Care; 2012 Aug; 24(4):330-7. PubMed ID: 22745358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Financial implications of starting a mobility protocol in a surgical intensive care unit.
    Knoblauch DJ; Bettis MA; Lundy F; Meldrum C
    Crit Care Nurs Q; 2013; 36(1):120-6. PubMed ID: 23221448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of Bow-tie methodology to improve patient safety.
    Abdi Z; Ravaghi H; Abbasi M; Delgoshaei B; Esfandiari S
    Int J Health Care Qual Assur; 2016 May; 29(4):425-40. PubMed ID: 27142951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond a safety breakthrough.
    Bush H
    Hosp Health Netw; 2009 Oct; 83(10):14-5. PubMed ID: 19960804
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term elimination of ICU infections requires specific steps.
    Traynor K
    Am J Health Syst Pharm; 2011 Oct; 68(19):1765-6. PubMed ID: 21930627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.